STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy

STRM.BIO, a start-up biotechnology company pioneering non-viral delivery technologies for in vivo cell and gene therapy, ...
CCN on MSN

S&P 500 Inclusion: Which Crypto Companies Made the Cut in 2025 — and Which Didn’t

Crypto-linked companies reached the scale and stability needed for S&P 500 inclusion in 2025. Strategy and other excluded ...
TipRanks on MSN

Private Markets: Prediction market platform Kalshi secures $300M

Kalshi, the prediction market platform, has raised a $300M Series D funding round. TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-backed insights and research tools you need ...
Barron's

Lunai Bioworks Inc.

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of ...